Abstract
Protein farnesyltransferase (FTase) catalyzes farnesylation of a variety of peptide substrates. 3H α-secondary kinetic isotope effect measurements of two peptide substrates, CVIM and CVLS, are significantly different and have been proposed to reflect a rate-limiting SN2-like transition state with dissociative characteristics for CVIM, while, due to the absence of an isotope effect, CVLS was proposed to have a rate-limiting peptide conformational change. Potential of mean force QM/MM studies coupled with umbrella sampling techniques were performed to further probe this mechanistic dichotomy. We observe the experimentally proposed TS for CVIM, but find that CVLS has a symmetric SN2 TS, which is also consistent with the absence of a 3H α-secondary kinetic isotope effect. These calculations demonstrate facile substrate- dependent alterations in the transition state structure catalyzed by FTase.
Keywords: FTase, farnesylation, zinc, mechanism, QM/MM, SCC-DFTB, PMF
Protein farnesyltransferase (FTase) and protein geranylgeranyltransferase type I (GGTase I) have been extensively studied, due to their involvement in cancer and potentially targets for cancer treatment1. Both enzymes catalyze the posttranslational attachment of a prenyl group (FTase: 15-carbon farnesyl, GGTase I: 20-carbon geranylgeranyl) to a cysteine residue in a conserved Ca1a2X sequence at or near the C-terminus of a protein (see Figure 1). C refers to cysteine, a1 is an amino acid with little sequence selectivity, a2 is an aliphatic amino acid, and X typically corresponds to alanine, serine, methionine (for FTase), phenylalanine (for FTase and GGTase I) or leucine (for GGTase I)2. This motif can be recognized and modified by FTase or GGTase I in the form of either a protein, like Ras, or a short peptide. Prenylation is essential to the function of a variety of enzymes including multiple Ras subfamily members, enabling them to localize to the cell membrane to play roles in signal regulation. Therefore, inhibition of prenylation could be used in the treatment of certain types of cancers by affecting the function of mutated Ras enzymes (found in about 30% of human cancers3). Indeed, several FTase inhibitors have entered Phase III clinical trial and have shown promise4.
Figure 1.
FTase catalyzed farnesylation. Important atoms are labeled.
FTase and GGTase I possess very similar overall structures: they share nearly identical α-subunits and highly homologous β-subunits. The binding pocket for their respective reactants, Ca1a2X and the corresponding isoprenoid diphosphate, are situated at the interface of two subunits, surrounded by the conserved residues, Lys164α, His248β (His219β), Arg291β (Arg263β), Lys294β (Lys266β) and Tyr300β (Tyr272β) (Residues in parenthesis refer to those in GGTase I throughout). Both enzymes require a zinc ion for catalytic activity. In their activated forms, zinc is coordinated to Cys1p (targeted Ca1a2X cysteine), Asp297β (Asp269β), Cys299β (Cys271β) and His362β (His321β), forming a tetrahedral cluster. Fierke and coworkers determined that Cys1p is a thiolate rather than a thiol based on pH dependence studies5. In the crystal structures (1QBQ6 and 1TN87 ~2Å resolution), the Zn2+-SCys299β distance is 0.1–0.2Å shorter than the Zn2+-SCys1p distance, suggesting weaker coordination between the zinc and peptide cysteine. This weak coordination has been proposed to enhance the nucleophilicity of the sulfur atom of the target cysteine that is essential for the SN2-like reaction8. In the crystal structure of FTase complexed with the prenylated K-Ras product (PDB code 1KZP9, 2.10Å resolution), the Zn2+-SCys1p distance increases to 2.66Å, providing additional support for this hypothesis9. FTase also requires a magnesium ion for optimal reactivity, but the position of this ion has not been observed crystallographically. Mutagenesis studies suggest that Asp352β coordinates magnesium10,11. Interestingly, in GGTase I, which is not activated by magnesium, this residue is a lysine (Lys311β) that has been proposed to functionally substitute for the Mg2+ ion12. Although farnesyl diphosphate (FPP) can exist as fully deprotonated form or its mono-protonated form (FPPH) at physiological pH in the absence of magnesium5, previous computational work suggested the FPPH form, with one of the β-diphosphate oxygen atoms protonated, is preferred in this situation.13
An important feature of the ternary (FTase/FPP/Ca1a2X) resting state (RS) is a C1-Sγ distance of over 7 Å. A conformational transition exclusively associated with FPP and the peptide substrate (not the enzyme) is required to close this gap prior the chemical step9,10,13,14 (see Figure S1). The catalytic mechanism of the subsequent chemical step has been debated for a number of years. Evidence supporting both a SN2-like mechanism (associative) and a SN1-like mechanism (dissociative) have been put forward15–17. However, recent experimental and computational studies strongly support an associative mechanism with dissociative characteristics18,19. Additionally, research carried out in Fierke lab revealed that substrate recognition by FTase is context dependent20, which illustrated that the identity of both X and a2 play important roles in the catalytic efficiency. Moreover, in 3H α-secondary kinetic isotope effect (α-SKIE) experiments, a value of near unity (1.00±0.04) was obtained for FTase catalyzing single turnover farnesylation of GCVLS while a significantly larger value (1.154±0.006) was observed for FTase with the peptide TKCVIF19. This difference was attributed to the presence of different rate-determining steps (RDS), which were proposed to involve the chemical step for FTase/TKCVIF, while for FTase/GCVLS the physical or conformational change step was hypothesized to be rate-limiting. This is an interesting observation given that the free energy of activation for farnesylation catalyzed by FTase is ~20 kcal/mol and the conformational change is localized to the substrates and not the enzyme (see Figure S1), which suggests that the peptide conformational transition is very highly constrained in FTase/GCVLS. Herein we describe studies testing this observation.
When we investigated the conformational transition step using potential of mean force (PMF) studies for the FTase/CVIM and FTase/CVLM complexes with classical molecular dynamics (MD) simulations, only small differences in the free energy barriers of the conformational step were observed13. This result indicated that a single change in the a2 position of the Ca1a2X motif was unable to alter the RDS, but did not address the situation where both X and a2 were altered in the Ca1a2X motif. Moreover, the details of the chemical step following the conformational step were not studied. Hence, a QM/MM study was carried out in order to further elucidate both the conformational and chemical steps in FTase catalysis. In fact, although MD simulations carried out at the molecular mechanical (MM) level provided useful insights into the conformational step in FTase13,21–23, theoretical studies at the QM/MM24 level add an extra dimension.18,25,26. In particular, in the chemical step where bond breaking and forming are important, classical MM theory is inappropriate. The self-consistent-charge density-functional tight-binding (SCC-DFTB) method has become a popular choice in QM/MM simulations, especially in zinc metalloenzymes and those cases involving phosphate reactions27–31. Moreover, SCC-DFTB/MM method has been extensively tested and good accuracy has been reported32–35. Furthermore, a recent SCC-DFTB based computational study by Roitberg and coworkers elucidated the catalytic mechanism and successfully reproduced the experimental KIE in trypanosoma cruzi transsialidase36. Hence, SCC-DFTB was adopted to study the farnesylation reaction catalyzed by both FTase/FPPH/CVIM (CVIM) and FTase/FPPH/CVLS (CVLS) complexes.
The acetyl-capped CVIM peptide represents the Ca1a2X motif of human K-Ras, the mutant of which is usually found in lung cancers. After equilibration with the QM/MM potential, a steered MD (SMD) simulation was conducted to propagate the trajectory along the reaction coordinate (RC) defined as the distance between the two reacting atoms: the C1 carbon from FPPH and the Sγ from the peptide cysteine. Including the C1-O1 bond into the RC results in an unphysical dissociative pathway and this same observation has been reported by Klein and coworkers18 (see SI for further comparisons between this work and Ref 18). The RC ranged from 1.8 Å to 8.0 Å (6.2 Å in total) that covered both the conformational and chemical steps. The free energy curve yielded a C1-Sγ distance of approximate 2.6 Å at the transition state (TS). This value is slightly longer than the 2.4–2.5Å TS C-S distance found in a model SN2 reaction studied at the MP2/6-31+G**//MP2-6-31+G* level of theory37. Subsequently, a set of umbrella sampling simulations (US) were carried out along the RC and the WHAM code38 was employed to construct the free energy profile. Our results indicate that farnesylation by FPPH, indeed, involves, an associative mechanism with dissociative character. The highest free energy barrier is 20.6 kcal/mol, and corresponds to the chemical step and is in excellent agreement with experimental results16,19 (see Figure 2). Moreover, the conformational transition along the reaction coordinate matches our previous MM study, with a 6.9 Å (7.2 Å from MM) RS, 5.3 Å (5.0 Å from MM) intermediate and an ~1.0 kcal/mol energy barrier separating them13. Importantly, another shallow intermediate state was identified between the 5.3 Å intermediate and the TS at around 3.9 Å, where the O1, C1 and Sγ atoms are aligned in a linear arrangement which is favorable for SN2 displacement. At the TS (see Figure 3), the H1-H2-C1-C2 dihedral is 169°, puckered slightly from a planar arrangement, moreover, the sign of this dihedral changes beyond this point, strengthening the point that the TS has been reached. The dC1-Sγ distance is 2.63Å, the C1-O1 bond is breaking and reaches 2.3–2.5Å, while Zn-Sγ distance shows a 0.05Å increase, indicating a weaker coordination between zinc and peptide cysteine. Beyond the TS, the dC1-Sγ continues decreasing, the dC1-O1 distance keeps quickly increasing until around 3.5 Å, and the dZn-Sγ reaches 2.50–2.55Å in the product state. Throughout the entire reaction, key residues in the FPPH binding pocket, such as Lys164α, His248β, Arg291β, Lys294β and Tyr300β, all form stabilizing hydrogen bonds with the diphosphate-leaving group. The Zn(II) coordination site is maintained during the process, but the dZn-Sγ increases from ~2.35Å to ~2.50Å. Such an increase has also been discovered in the crystal structures reported by Long, et al.9. Additionally, Fierke and coworkers have proposed that a weak zinc-sulfur coordination enhances the nucleophilicity of Sγ8. Qualitatively, our observed increase of the dZn-Sγ distance supports the notion of the enhanced nucleophilicity at Sγ.
Figure 2.
Free energy profile of farnesylation catalyzed by FTase/FPPH/CVIM (red) and FTase/FPPH/CVLS (blue).
Figure 3.
TS active site snapshots of FTase/FPPH/CVIM (left) and FTase/FPPH/CVLS (right). Also see Figure S4.
The acetyl-capped CVLS peptide has the same Ca1a2X sequence as H-Ras, whose malfunction has been implicated in bladder cancers. The PMF study was carried out on both the physical step (at the MM level) and chemical step (at the QM/MM level). The free energy barrier associated with the conformational transition is ~2.8 kcal/mol. This value is of the same order of magnitude as observed for CVIM (~1.0 kcal/mol, at both QM/MM and MM level), FTase/FPPH/CVLM (~2.5 kcal/mol) and Yβ300F/FPPH/CVIM (~1.4 kcal/mol). Obviously, such a small barrier is insufficient to cause the predicted RDS change. In fact, the experimental free energy barrier height for FTase/GCVLS is 20 kcal/mol (in the absence of Mg2+), while our QM/MM results gave a 21.3 kcal/mol free energy barrier, not for the physical step, but for the chemical step. Hence, another hypothesis needs to be developed to explain the observed near unity 3H α-SKIE measurement. However, the possibility that an upstreaming sequence (TK) also influences α-SKIE cannot be excluded and is being explored.
α-SKIEs are useful in distinguishing SN1 and SN2 reaction types because they are sensitive to bond hybridization changes and the resultant changes in zero point energies (ZPEs). In a typical symmetrical SN2 reaction, kH/kT tends to be smaller and near unity (~1.00±0.06), while the values observed for SN1 reactions are ~1.1–1.239. In the CVLS chemistry step, dC1-Sγ at the TS is 2.51 Å (see Figure 3), which is 0.12 Å shorter than what was found for CVIM, and much closer to the value reported by Gronert et al. in their study of a related SN2 reaction involving sulfur at the MP2/6-31+G**//MP2-6-31+G* level of theory37. At the TS, the O1, C1 of FPPH and Sγ of Cys1p are nearly co-linear with only C1 being slightly out of plane and the C1-O1 bond is more constrained, reaching only 1.8–2.0Å and continues to slowly increase beyond the TS. The H1-H2-C1-C2 dihedral is nearly planar in the TS with a value of 179.6°, which decreases rapidly on both sides of this peak (see Figure S2). Hence, the structural evidence supports a more typical SN2-like TS. During this reaction, the binding pocket amino acids do not experience large fluctuations, further confirming that an enzyme based conformational change that large enough to alter the RDS is unlikely. The Zn(II) coordination site is maintained during the process with the dZn-Sγ increasing by about 0.1Å.
As mentioned previously, the most important factor in the differences between kH and kT is the ZPE. In the light of this, we performed a QM optimization followed by frequency analysis with the M06-2X/6-31+G** level of theory40,41, on the QM part of the system abstracted from the prenylation TSs for CVIM and CVLS, respectively. Subsequently, we calculated the ΔΔEZPE for both CVLS and CVIM, based on: ΔΔEZPE=ΔEZPE T-ΔEZPE H, where ΔEZPE=EZPE TS-EZPE GS for both H and T. A ~0.12 kcal/mol difference of ΔΔEZPE was identified, with the CVIM complex possessing the larger ΔΔEZPE (0.15±0.02 kcal/mol) and the CVLS complex having a ΔΔEZPE near zero (0.01±0.01 kcal/mol). This strengthens our proposal that the CVLS peptide prefers a SN2-like reaction pathway. Moreover, these results are qualitatively in accordance with the experimental trends (an approximate 0.085 kcal/mol ΔΔG for FTase/TKCVIF in the absence of Mg2+, see SI). More importantly, it demonstrates that the slight differences observed in the reaction mechanisms reflect the experimentally observed kH/kT differences. We also qualitatively monitored charge variation through the reaction course of CVLS and CVIM prenylation using Mulliken charges. The summation of the charges on the C1, C2 and C3 atoms (comprising an allyl like group) of the farnesyl group are of particular interest, because in a dissociative reaction pathway the developing partial positive charge would be delocalized across this allyl fragment, while in a pure SN2 reaction less positive charge would be developed in the TS. For CVIM +0.032q is delocalized into the ally moiety, which is ten times smaller (+0.003q) in CVLS. This result strengthens our conclusion that the reaction mechanism for CVLS is a typical SN2 reaction (synchronous ANDN) and an associative mechanism with dissociative characteristics (dissociative ANDN) for CVLM. Providing further support for our results is the agreement between the computed and experimental free energies of activation. The free energy barrier for the CVLS peptide was computed to be 21.3 kcal/mol, in excellent agreement with the 20.0 kcal/mol experimental value16. In addition, the computed free energy barrier difference between CVLS and CVIM is approximately 0.8 kcal/mol, which also is in agreement with the experimentally observed ~0.5 kcal/mol difference (although the experimental result is measured in the presence of Mg2+)20.
The residues in the a2 and X positions in the Ca1a2X motif have been shown to strongly affect substrate selection, with selection of the side chain at the a2 position dependent on both hydrophicity and volume20. The different behavior of the a2 residue between CVIM and CVLS was monitored via a modified Ramachandran plot. In this plot, we monitored the a2 residue in terms of Ψ-Φ torsion angles throughout the chemical step (see Figure S3), for both complexes. In CVIM, the Ile3p remained in the α-region, while for CVLS Leu3p fluctuates in the transition region connecting the α- and β-regions. We propose that in the CVLS system the peptide sacrifices its conformational stability to facilitate bringing the two substrates together, while for CVIM the peptide remains in the α-region, so the energetic cost of the conformational step is mainly attributed to the rotation of FPPH. Preliminary results show that for CVLM, the Leu3p also remains in the α-region (see Figure S3). Therefore, it appears that the differential a2 behavior observed in the CVLS and CVIM (/CVLM) complexes cannot be fully attributed to a single change at the a2 position but to a double change at the a2 and X positions, in support of the context- dependent substrate recognition hypothesis of Fierke and co-workers20.
In conclusion, we have put forth an alternative proposal for FTase catalysis that involves differential SN1/SN2-like behaviors as a function of the peptide to be farnesylated. Thus, FTase activity appears to be fully governed by the chemical step with the conformational step only playing a modest role. Furthermore, the small energetic differences between the SN1 and SN2 transition states in the enzymes allow substrate dependent alteration in the transition state structure.
Supplementary Material
ACKNOWLEDGMENT
The authors thank Dr. Adrian E. Roitberg and Dr. Nicole A. Horenstein and Dr. June Pais for helpful discussions, and the NIH for financial support this project through grants (GM044974) to K.M.M and (GM040602) for C.A.F.. We also thank Dr. Qiang Cui for sharing phosphors parameters for SCC-DFTB.
Funding Sources
ABBREVIATIONS
- FTase
protein farnesyltransferase
- TS
transition state
- RS
resting state
- (S)KIE
(secondary) kinetic isotope effect
- RDS
rate-determining step
- PMF
potential of mean force
- MD
molecular dynamics
- QM/MM
quantum mechanical molecular mechanical
- SCC-DFTB
self-consistent-charge density-functional tight-binding
- RC
reaction coordinate
- SMD
steered molecular dynamics
- US
umbrella sampling
Footnotes
ASSOCIATED CONTENT
Supporting Information. Methods and computation details, short trajectory movies and key structures. This material is available free of charge via the Internet at http://pubs.acs.org.
REFERENCES
- 1.Zhang FL, Casey PJ. Annu. Rev. Biochem. 1996;65:241–269. doi: 10.1146/annurev.bi.65.070196.001325. [DOI] [PubMed] [Google Scholar]
- 2.Lamphear CL, Zverina EA, Hougland JL, Fierke CA. The Enzymes-Protein prenylation/Part A. 2011;29:207–234. [Google Scholar]
- 3.Cox AD. Drugs. 2001;61:723–732. doi: 10.2165/00003495-200161060-00002. [DOI] [PubMed] [Google Scholar]
- 4.Doll RJ, Kirschmeier P, Bishop WR. Curr. Opin. Drug Discovery Dev. 2004;7:478–486. [PubMed] [Google Scholar]
- 5.Saderholm MJ, Hightower KE, Fierke CA. Biochemistry. 2000;39:12398–12405. doi: 10.1021/bi0011781. [DOI] [PubMed] [Google Scholar]
- 6.Strickland CL, Windsor WT, Syto R, Wang L, Bond R, Wu Z, Schwartz J, Le HV, Beese LS, Weber PC. Biochemistry. 1998;37:16601–16611. doi: 10.1021/bi981197z. [DOI] [PubMed] [Google Scholar]
- 7.Reid TS, Terry KL, Casey PJ, Beese LS. J. Mol. Biol. 2004;343:417–433. doi: 10.1016/j.jmb.2004.08.056. [DOI] [PubMed] [Google Scholar]
- 8.Tobin DA, Pickett JS, Hartman HL, Fierke CA, Penner-Hahn JE. J. Am. Chem. Soc. 2003;125:9962–9969. doi: 10.1021/ja035927o. [DOI] [PubMed] [Google Scholar]
- 9.Long SB, Casey PJ, Beese LS. Nature. 2002;419:645–650. doi: 10.1038/nature00986. [DOI] [PubMed] [Google Scholar]
- 10.Pickett JS, Bowers KE, Fierke CA. J. Biol. Chem. 2003;278:51243–51250. doi: 10.1074/jbc.M309226200. [DOI] [PubMed] [Google Scholar]
- 11.Yang Y, Chakravorty DK, Merz KM. Biochemistry. 2010;49:9658–9666. doi: 10.1021/bi1008358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Hartman HL, Bowers KE, Fierke CA. J. Biol. Chem. 2004;279:30546–30553. doi: 10.1074/jbc.M403469200. [DOI] [PubMed] [Google Scholar]
- 13.Cui G, Merz KM., Jr Biochemistry. 2007;46:12375–12381. doi: 10.1021/bi701324t. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Long SB, Hancock PJ, Kral AM, Hellinga HW, Beese LS. Proc. Natl. Acad. Sci. U. S. A. 2001;98:12948–12953. doi: 10.1073/pnas.241407898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Dolence JM, Poulter CD. Proc. Natl. Acad. Sci. U. S. A. 1995;92:5008–5011. doi: 10.1073/pnas.92.11.5008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Huang CC, Hightower KE, Fierke CA. Biochemistry. 2000;39:2593–2602. doi: 10.1021/bi992356x. [DOI] [PubMed] [Google Scholar]
- 17.Edelstein RL, Weller VA, Distefano MD, Tung JS. J. Org. Chem. 1998;63:5298–5299. [Google Scholar]
- 18.Ho MH, Vivo MD, Peraro MD, Klein ML. J. Chem. Theory Comput. 2009;5:1657–1666. doi: 10.1021/ct8004722. [DOI] [PubMed] [Google Scholar]
- 19.Pais JE, Bowers KE, Fierke CA. J. Am. Chem. Soc. 2006;128:15086–15087. doi: 10.1021/ja065838m. [DOI] [PubMed] [Google Scholar]
- 20.Hougland JL, Lamphear CL, Scott SA, Gibbs RA, Fierke CA. Biochemistry. 2009;48:1691–1701. doi: 10.1021/bi801710g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Cui G, Wang B, Merz KM., Jr Biochemistry. 2005;44:16513. doi: 10.1021/bi051020m. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Cui G, Li X, Merz KM., Jr Biochemistry. 2006;46:1303–1311. doi: 10.1021/bi062076z. [DOI] [PubMed] [Google Scholar]
- 23.Sousa SF, Fernandes PA, Ramos MJ. Bioorg. Med. Chem. 2009;17:3369–3378. doi: 10.1016/j.bmc.2009.03.055. [DOI] [PubMed] [Google Scholar]
- 24.Warshel A, Levitt M. J. Mol. Biol. 1976;103:227–249. doi: 10.1016/0022-2836(76)90311-9. [DOI] [PubMed] [Google Scholar]
- 25.Sousa SF, Fernandes PA, Ramos MJ. Chemistry-a European Journal. 2009;15:4243–4247. doi: 10.1002/chem.200802745. [DOI] [PubMed] [Google Scholar]
- 26.Sousa SF, Fernandes PA, Ramos MJ. Proteins-Structure Function and Bioinformatics. 2007;66:205–218. doi: 10.1002/prot.21219. [DOI] [PubMed] [Google Scholar]
- 27.Elstner M, Porezag D, Jungnickel G, Elsner J, Haugk M, Frauenheim T, Suhai S, Seifert G. Physical Review B. 1998;58:7260–7268. [Google Scholar]
- 28.Elstner M, Cui Q, Munih P, Kaxiras E, Frauenheim T, Karplus M. J. Comput. Chem. 2003;24:565–581. doi: 10.1002/jcc.10201. [DOI] [PubMed] [Google Scholar]
- 29.Yang Y, Yu HB, York D, Elstner M, Cui Q. J. Chem. Theory Comput. 2008;4:2067–2084. doi: 10.1021/ct800330d. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Moreira NH, Dolgonos G, Aradi B, da Rosa AL, Frauenheim T. J. Chem. Theory Comput. 2009;5:605–614. doi: 10.1021/ct800455a. [DOI] [PubMed] [Google Scholar]
- 31.Elstner M, Gaus MGM, Cui QA. J. Chem. Theory Comput. 2011;7:931–948. doi: 10.1021/ct100684s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Guo H, Guo HB, Rao N, Xu Q. J. Am. Chem. Soc. 2005;127:3191–3197. doi: 10.1021/ja0439625. [DOI] [PubMed] [Google Scholar]
- 33.Guo H, Xu D, Cui G. J. Am. Chem. Soc. 2007;129:10814–10822. doi: 10.1021/ja072532m. [DOI] [PubMed] [Google Scholar]
- 34.Xu DG, Guo H. J. Am. Chem. Soc. 2009;131:9780–9788. doi: 10.1021/ja9027988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Xu DG, Wu SS, Guo H. J. Am. Chem. Soc. 2010;132:17986–17988. doi: 10.1021/ja104241g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Pierdominici-Sottile G, Horenstein NA, Roitberg AE. Biochemistry. 2011;50:10150–10158. doi: 10.1021/bi2009618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Gronert S, Lee JM. J. Org. Chem. 1995;60:6731–6736. [Google Scholar]
- 38.Grossfield A. 1.6d ed. [Google Scholar]
- 39.Purich DL, Allison RD. Handbook of Biochemical Kinetics. San Diego, CA: Academic Press; 2000. [Google Scholar]
- 40.Truhlar DG, Zhao Y. Theor. Chem. Acc. 2008;120:215–241. [Google Scholar]
- 41.Truhlar DG, Zhao Y. Acc. Chem. Res. 2008;41:157–167. doi: 10.1021/ar700111a. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



